Pharmacokinetics of ketamine and its metabolite, norketamine, after intravenous administration of a bolus of ketamine to isoflurane-anesthetized dogs

American Journal of Veterinary Research

Volumn 66, Issue 12, 2005, Pages 2034-2038

  Pypendop, Bruno H ^a   Ilkiw, Jan E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ISOFLURANE; KETAMINE; NORKETAMINE; UNCLASSIFIED DRUG;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CENTRIFUGATION; COMPARTMENT MODEL; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG HALF LIFE; FREEZING; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; STEADY STATE;

ANESTHETICS, INHALATION; ANIMALS; CHROMATOGRAPHY, LIQUID; DOGS; INJECTIONS, INTRAVENOUS; ISOFLURANE; KETAMINE; MASS SPECTROMETRY; MODELS, BIOLOGICAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 33645217785     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.2034     Document Type: Article

References (44)

1. Buch U, Altmayer P, Isenberg JC, et al. Increase of thiopental concentration in rat tissues due to anesthesia with isoflurane. Methods Find Exp Clin Pharmacol 1991;13:687-691.
2. Chelly JE, Hysing ES, Abernethy DR, et al. Role of isoflurane on hemodynamic properties and disposition of nicardipine. J Pharmacol Exp Ther 1987;241:899-906.
3. Nishiyama T, Matsukawa T, Hanaoka K, et al. Interactions between nicardipine and enflurane, isoflurane, and sevoflurane. Can J Anaesth 1997;44:1071-1076.
4. Xue F, Sun B, Zou Q, et al. Effects of enflurane and isoflurane anesthesia on the pharmacokinetics of pancuronium in adult patients. Chin Med J (Engl) 1996;109:233-237.
5. Frink EJ Jr, Morgan SE, Coetzee A, et al. The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology 1992;76:85-90.
6. Gelman S, Fowler KC, Smith LR. Liver circulation and function during isoflurane and halothane anesthesia. Anesthesiology 1984;61:726-730.
7. Hughes RL, Campbell D, Fitch W. Effects of enflurane and halothane on liver blood flow and oxygen consumption in the greyhound. Br J Anaesth 1980;52:1079-1086.
8. Pagel PS, Kampine JP, Schmeling WT, et al. Comparison of the systemic and coronary hemodynamic actions of desflurane, isoflurane, halothane, and enflurane in the chronically instrumented dog. Anesthesiology 1991;74:539-551.
9. Steffey EP. Inhalation anesthetics. In: Thurmon JC, Tranquilli WJ, Benson GJ, eds. Lumb & Jones' veterinary anesthesia. 3rd ed. Baltimore: The Williams & Wilkins Co, 1996;297-329.
10. Steffey EP, Howland D Jr. Isoflurane potency in the dog and cat. Am J Vet Res 1977;38:1833-1836.
11. Steffey EP, Gillespie JR, Berry JD, et al. Circulatory effects of halothane and halothane-nitrous oxide anesthesia in the dog: controlled ventilation. Am J Vet Res 1974;35:1289-1293.
12. Steffey EP, Gillespie JR, Berry JD, et al. Circulatory effects of halothane and halothane-nitrous oxide anesthesia in the dog: spontaneous ventilation. Am J Vet Res 1975;36:197-200.
13. Erhardt W, Haberstroh J, Schindele M, et al. The principle of "balanced anesthesia" in high risk canine patients [in German]. Tierarztl Prax 1988;16:179-185.
14. Muir WW. Balanced anaesthesia: new emphasis on an old idea. J Vet Anaesth 1994;21:9-11.
15. Farver TB, Haskins SC, Patz JD. Cardiopulmonary effects of acepromazine and of the subsequent administration of ketamine in the dog. Am J Vet Res 1986;47:631-635.
16. Jalanka H, Skutnabb K, Damsten Y. Preliminary results on the use of medetomidine-ketamine combinations in the dog. Acta Vet Scand Suppl 1989;85:125-127.
17. Kolata RJ, Rawlings CA. Cardiopulmonary effects of intravenous xylazine, ketamine, and atropine in the dog. Am J Vet Res 1982;43:2196-2198.
18. Navarro JA, Friedman JR. A clinical evaluation of xylazine and ketamine HCL for cesarean section in the dog. Vet Med Small Anim Clin 1975;70:1075-1079.
19. DeYoung DW, Paddleford RR, Short CE. Dissociative anesthetics in the cat and dog. J Am Vet Med Assoc 1972;161:1442-1445.
20. Hartsfield SM. Advantages and guidelines for using ketamine for induction of anesthesia. Vet Clin North Am Small Anim Pract 1992;22:266-267.
21. Muir WW III, Sams R. Effects of ketamine infusion on halothane minimal alveolar concentration in horses. Am J Vet Res 1992;53:1802-1806.
22. Schwieger IM, Szlam F, Hug CC Jr. The pharmacokinetics and pharmacodynamics of ketamine in dogs anesthetized with enflurane. J Pharmacokinet Biopharm 1991;19:145-156.
23. White PF, Johnston RR, Pudwill CR. Interaction of ketamine and halothane in rats. Anesthesiology 1975;42:179-186.
24. Muir WW III, Wiese AJ, March PA. Effects of morphine, lidocaine, ketamine, and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane. Am J Vet Res 2003;64:1155-1160.
25. Wagner AE, Walton JA, Hellyer PW, et al. Use of low doses of ketamine administered by constant rate infusion as an adjunct for postoperative analgesia in dogs. J Am Vet Med Assoc 2002;221:72-75.
26. Henthorn TK, Krejcie TC, Niemann CU, et al. Ketamine distribution described by a recirculatory pharmacokinetic model is not stereoselective. Anesthesiology 1999;91:1733-1743.
27. Kaka JS, Hayton WL. Pharmacokinetics of ketamine and two metabolites in the dog. J Pharmacokinet Biopharm 1980;8:193-202.
28. Roncada P, Zaghini A, Riciputi C, et al. Kinetics of ketamine plasma and urine metabolite levels following intravenous administration in the dog. Vet Res Commun 2003;27(suppl 1):433-436.
29. Solano A, Pypendop BH, Boscan P, et al. Effect of intravenous ketamine administration on the minimum alveolar concentration of isoflurane in anesthetized dogs. Am J Vet Res 2006;67:in press.
30. Gibaldi M, Perrier D. Multicompartment models. In: Gibaldi M, ed. Pharmacokinetics. 2nd ed. New York: Marcell Dekker Inc, 1982;45-109.
31. Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-175.
32. Baggot JD, Blake JW. Disposition kinetics of ketamine in the domestic cat. Arch Int Pharmacodyn Ther 1976;220:115-124.
33. Kaka JS, Klavano PA, Hayton WL. Pharmacokinetics of ketamine in the horse. Am J Vet Res 1979;40:978-981.
34. Wieber J, Gugler R, Hengstmann JH, et al. Pharmacokinetics of ketamine in man. Anaesthesist 1975;24:260-263.
35. Waterman AE, Robertson SA, Lane JG. Pharmacokinetics of intravenously administered ketamine in the horse. Res Vet Sci 1987;42:162-166.
36. Steffey EP, Howland D Jr. Potency of enflurane in dogs: comparison with halothane and isoflurane. Am J Vet Res 1978;39:573-577.
37. Adams JD Jr, Baillie TA, Trevor AJ, et al. Studies on the biotransformation of ketamine. I - Identification of metabolites produced in vitro from rat liver microsomal preparations. Biomed Mass Spectrom 1981;8:527-538.
38. Leung LY, Baillie TA. Studies on the biotransformation of ketamine. II - Quantitative significance of the N-demethylation pathway in rats in vivo determined by a novel stable isotope technique. Biomed Environ Mass Spectrom 1989;18:401-404.
39. Woolf TF, Adams JD. Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations. Xenobiotica 1987; 17:839-847.
40. Leung LY, Baillie TA. Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine. J Med Chem 1986;29:2396-2399.
41. Riviere JE. Population pharmacokinetic models and Bayesian forecasting. In: Comparative pharmacokinetics: principles, techniques, and applications. Ames, Iowa: Iowa State University Press, 1999;259-282.
42. Evans WE, Johnson JA. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet 2001;2:9-39.
43. Palmer SN, Giesecke NM, Body SC, et al. Pharmacogenetics of anesthetic and analgesic agents. Anesthesiology 2005;102:663-671.
44. Spielberg SP. N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism. J Pharmacokinet Biopharm 1996;24:509-519.